Simulations PlusFRA:SD3 67 FCF Margin % is 22.97% as of Feb. 2026, which is 1% above its 10-year median of 22.74. GuruFocus rates FRA:SD3 with a GF Score™ of 67/100 and a GF Value™ of €32.93 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Simulations Plus ranks better than 95.64% on this metric.
The historical rank and industry rank for Simulations Plus's FCF Margin % or its related term are showing as below:
FRA:SD3'
s FCF Margin % Range Over the Past 10 Years
Min: 12.88 Med: 22.74 Max: 31.48
Current: 25.86
During the past 13 years, the highest FCF Margin % of Simulations Plus was 31.48%. The lowest was 12.88%. And the median was 22.74%.
FRA:SD3's FCF Margin % is ranked better than 95.64% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 3.34
vs FRA:SD3: 25.86
Simulations Plus FCF Margin % Related Terms
Simulations Plus FCF Margin % Historical Data
* Premium members only.
The historical data trend for Simulations Plus's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:SD3 vs TBRG, CARL, NRC: FCF Margin % Comparison
For the Health Information Services subindustry, Simulations Plus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simulations Plus FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Simulations Plus's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simulations Plus (FRA:SD3) has a FCF Margin % of 22.97% as of Feb. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Simulations Plus and its competitors. This is near median its historical median of 22.74. Over the past decade, Simulations Plus' FCF Margin % has ranged from 12.88 to 31.48. According to the industry distribution chart, Simulations Plus ranks #29 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 4.4%.
Is Simulations Plus' FCF Margin % too high?
Simulations Plus' current FCF Margin % of 22.97% is near median its 10-year median of 22.74. Over the past 10 years, this metric has ranged from a low of 12.88 to a high of 31.48. The Healthcare Providers & Services industry median FCF Margin % is 3.34. Simulations Plus' value of 22.97% is 587.7% above this industry median. Based on the distribution chart, Simulations Plus ranks #29 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Simulations Plus has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' FCF Margin % compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #29 out of 665 companies for FCF Margin %. This places Simulations Plus in the top 4% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.34. Simulations Plus' value of 22.97% is 587.7% above this benchmark. Historically, Simulations Plus' own FCF Margin % has ranged from 12.88 to 31.48 over the past decade. While the company's 10-year median is 22.74 vs. the industry median of 3.34, Simulations Plus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.34, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current FCF Margin % of 22.97% is 587.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current FCF Margin % is 22.97%, which is near median its own 10-year median of 22.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (FRA:SD3) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.93, compared to a current price of €15.80 — trading 52% below its estimated fair value. The current FCF Margin % is 22.97%, which is near median its 10-year median of 22.74 and 587.7% above the Healthcare Providers & Services industry median of 3.34. Simulations Plus' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Simulations Plus (FRA:SD3), the current FCF Margin % is 22.97% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simulations Plus (FRA:SD3) Overvalued in 2026?
Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued.
The current stock price of €15.80 is trading 52% below its estimated GF Value™ of €32.93.
GuruFocus considers Simulations Plus to be Significantly Undervalued.
Key valuation signals for FRA:SD3:
FCF Margin %: 22.97% (near median its 10-year median of 22.74)
GF Value™: €32.93 vs. price of €15.80 (52% below fair value)
Industry Position: 587.7% above the Healthcare Providers & Services median (#29 of 665)
No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
67GF Score
Get the complete analysis for FRA:SD3
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SD3 has been successfully added to your 
